J. M. Ordóñez

A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma

C. Balañà, P. Pérez-Segura, O. Gallego, 2015, Clinical and Translational Oncology.

IMPACTS OF CLIMATIC CHANGE IN SPAIN

C., R. Trigo, M., 2005 .

Factors Determining the Actual Received Dose Intensity in a Program of Multicyclic Dose-Intensive Alternating Chemotherapy with Sequential Stem Cell Support

T. Ramón Y Cajal, A. Brugarolas, J. Pérez-Calvo, 2001, Acta Haematologica.

Second-Line Chemotherapy With Irinotecan and Vinorelbine in Stage IIIB and IV Non–Small-Cell Lung Cancer: A Phase II Study

A. Brugarolas, J. Aristu, J. M. Ordóñez, 2002, American journal of clinical oncology.

Bevacizumab in combination with TMZ in patients with recurrent GBM: Final OS and PFS analysis.

C. Balañà, O. Gallego, J. Sepúlveda, 2013 .